Sep 25, 2017 20:05 pm UTC| Business
SEATTLE, Sept. 25, 2017 -- Global supercomputer leader Cray Inc. (Nasdaq:CRAY) today announced it has completed the previously announced transaction and strategic partnership with Seagate centered around the addition of...
Neuralstem Announces the Appointment of Two New Members to the Board of Directors
Sep 25, 2017 20:05 pm UTC| Business
GERMANTOWN, Md., Sept. 25, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Zhang Zhuo and Cristina Csimma, PharmD, MHP,...
TTM Technologies, Inc. Announces Upcoming Conference Participation
Sep 25, 2017 20:05 pm UTC| Business
COSTA MESA, Calif., Sept. 25, 2017 -- TTM Technologies, Inc. (NASDAQ:TTMI), a leading global printed circuit board (PCB) manufacturer, today announced that members of its management team will present at the The Deutsche...
Zumiez Announces Participation in the B. Riley & Co. 3rd Annual Consumer Conference
Sep 25, 2017 20:05 pm UTC| Business
LYNNWOOD, Wash., Sept. 25, 2017 -- Zumiez Inc. (NASDAQ:ZUMZ) a leading specialty retailer of apparel, footwear, equipment and accessories for young men and women, today announced that management will present at the B....
athenahealth, Inc. Announces Third Quarter 2017 Earnings Conference Call
Sep 25, 2017 20:01 pm UTC| Business
WATERTOWN, Mass., Sept. 25, 2017 -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider of network-enabled services and point-of-care mobile applications for hospital and ambulatory clients nationwide, today announced...
Sep 25, 2017 20:01 pm UTC| Business
Share Exchange Strengthens Balance Sheet and Eliminates a Total of $4 Million of Interest Expense Over 4 Years HORSHAM, Pa., Sept. 25, 2017 -- STRATA Skin Sciences, Inc. (“STRATA”) (NASDAQ:SSKN), a medical...
Iovance Biotherapeutics, Inc. Announces Closing of $57.5 Million Common Stock Public Offering
Sep 25, 2017 20:01 pm UTC| Business
SAN CARLOS, Calif., Sept. 25, 2017 -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced...